Qiqilian ameliorates vascular endothelial dysfunction by inhibiting NLRP3-ASC inflammasome activation <i>in vivo</i> and <i>in vitro</i>-Reference-Cited by-同舟云学术

Qiqilian ameliorates vascular endothelial dysfunction by inhibiting NLRP3-ASC inflammasome activation in vivo and in vitro

Author:

Luo Yuan¹,Tan Zhenyuan²,Ye Yun³,Ma Xiaocong⁴,Yue Guihua⁵⁶

Affiliation:

1. The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, P.R. China

2. Guangxi Medical University, Nanning, P.R. China

3. No. 923 Hospital of the PLA Joint Logistics Support Force, Nanning, P.R. China

4. Guangxi University of Chinese Medicine, Nanning, P.R. China

5. Guangxi Internation Zhuang Medicine Hospital to Guangxi University of Chinese Medicine, Nanning, P.R. China

6. Guangxi Internation Zhuang Medicine Hospital, Nanning, P.R. China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Link

Reference39 articles.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献